avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hnf4g
|
ENSMUSG00000017688.8 | hepatocyte nuclear factor 4, gamma |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hnf4g | mm10_v2_chr3_+_3634145_3634161 | -0.51 | 1.7e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_+_39287074 | 28.10 |
ENSMUST00000003137.8
|
Cyp2c29
|
cytochrome P450, family 2, subfamily c, polypeptide 29 |
chr17_-_46438471 | 24.97 |
ENSMUST00000087012.5
|
Slc22a7
|
solute carrier family 22 (organic anion transporter), member 7 |
chr19_+_39007019 | 17.73 |
ENSMUST00000025966.4
|
Cyp2c55
|
cytochrome P450, family 2, subfamily c, polypeptide 55 |
chr5_+_146079254 | 17.18 |
ENSMUST00000035571.8
|
Cyp3a59
|
cytochrome P450, family 3, subfamily a, polypeptide 59 |
chr5_-_87337165 | 17.00 |
ENSMUST00000031195.2
|
Ugt2a3
|
UDP glucuronosyltransferase 2 family, polypeptide A3 |
chr16_-_18089022 | 16.89 |
ENSMUST00000132241.1
ENSMUST00000139861.1 ENSMUST00000003620.5 |
Prodh
|
proline dehydrogenase |
chr9_-_46235631 | 16.84 |
ENSMUST00000118649.1
|
Apoc3
|
apolipoprotein C-III |
chr9_-_46235260 | 14.81 |
ENSMUST00000121916.1
ENSMUST00000034586.2 |
Apoc3
|
apolipoprotein C-III |
chr15_-_82764176 | 14.37 |
ENSMUST00000055721.4
|
Cyp2d40
|
cytochrome P450, family 2, subfamily d, polypeptide 40 |
chr17_-_32917048 | 13.37 |
ENSMUST00000054174.7
|
Cyp4f14
|
cytochrome P450, family 4, subfamily f, polypeptide 14 |
chr11_-_5915124 | 12.75 |
ENSMUST00000109823.2
ENSMUST00000109822.1 |
Gck
|
glucokinase |
chr4_-_62087261 | 12.70 |
ENSMUST00000107488.3
ENSMUST00000107472.1 ENSMUST00000084531.4 |
Mup3
|
major urinary protein 3 |
chr7_-_99695628 | 12.50 |
ENSMUST00000145381.1
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr10_+_127801145 | 12.31 |
ENSMUST00000071646.1
|
Rdh16
|
retinol dehydrogenase 16 |
chr7_+_46751832 | 12.09 |
ENSMUST00000075982.2
|
Saa2
|
serum amyloid A 2 |
chr2_+_173153048 | 11.62 |
ENSMUST00000029017.5
|
Pck1
|
phosphoenolpyruvate carboxykinase 1, cytosolic |
chr4_+_115411624 | 11.39 |
ENSMUST00000094887.3
|
Cyp4a12b
|
cytochrome P450, family 4, subfamily a, polypeptide 12B |
chr1_+_74713551 | 11.22 |
ENSMUST00000027356.5
|
Cyp27a1
|
cytochrome P450, family 27, subfamily a, polypeptide 1 |
chr7_-_99695572 | 11.07 |
ENSMUST00000137914.1
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr16_-_18413452 | 10.98 |
ENSMUST00000165430.1
ENSMUST00000147720.1 |
Comt
|
catechol-O-methyltransferase |
chr19_-_8405060 | 10.83 |
ENSMUST00000064507.5
ENSMUST00000120540.1 ENSMUST00000096269.4 |
Slc22a30
|
solute carrier family 22, member 30 |
chr19_+_39992424 | 10.74 |
ENSMUST00000049178.2
|
Cyp2c37
|
cytochrome P450, family 2. subfamily c, polypeptide 37 |
chr4_+_63362443 | 10.71 |
ENSMUST00000075341.3
|
Orm2
|
orosomucoid 2 |
chr8_+_104733997 | 10.59 |
ENSMUST00000034346.8
ENSMUST00000164182.2 |
Ces2a
|
carboxylesterase 2A |
chr17_-_32917320 | 10.50 |
ENSMUST00000179434.1
|
Cyp4f14
|
cytochrome P450, family 4, subfamily f, polypeptide 14 |
chr19_-_39463067 | 10.29 |
ENSMUST00000035488.2
|
Cyp2c38
|
cytochrome P450, family 2, subfamily c, polypeptide 38 |
chr4_-_60139857 | 10.28 |
ENSMUST00000107490.4
ENSMUST00000074700.2 |
Mup2
|
major urinary protein 2 |
chr15_+_10223974 | 10.28 |
ENSMUST00000128450.1
ENSMUST00000148257.1 ENSMUST00000128921.1 |
Prlr
|
prolactin receptor |
chr10_-_24927444 | 10.10 |
ENSMUST00000020161.8
|
Arg1
|
arginase, liver |
chr8_-_93079965 | 9.60 |
ENSMUST00000109582.1
|
Ces1b
|
carboxylesterase 1B |
chr15_+_82555087 | 9.60 |
ENSMUST00000068861.6
|
Cyp2d12
|
cytochrome P450, family 2, subfamily d, polypeptide 12 |
chr5_-_113081579 | 9.43 |
ENSMUST00000131708.1
ENSMUST00000117143.1 ENSMUST00000119627.1 |
Crybb3
|
crystallin, beta B3 |
chr10_+_40629987 | 9.40 |
ENSMUST00000019977.7
|
Ddo
|
D-aspartate oxidase |
chr9_+_44673227 | 9.32 |
ENSMUST00000034609.4
ENSMUST00000071219.5 |
Treh
|
trehalase (brush-border membrane glycoprotein) |
chr8_-_94696223 | 9.21 |
ENSMUST00000034227.4
|
Pllp
|
plasma membrane proteolipid |
chr4_-_61674094 | 8.96 |
ENSMUST00000098040.3
|
Mup18
|
major urinary protein 18 |
chr8_-_109579056 | 8.79 |
ENSMUST00000074898.6
|
Hp
|
haptoglobin |
chr4_-_115496129 | 8.74 |
ENSMUST00000030487.2
|
Cyp4a14
|
cytochrome P450, family 4, subfamily a, polypeptide 14 |
chr16_+_91269759 | 8.63 |
ENSMUST00000056882.5
|
Olig1
|
oligodendrocyte transcription factor 1 |
chr5_-_145879857 | 8.57 |
ENSMUST00000035918.7
|
Cyp3a11
|
cytochrome P450, family 3, subfamily a, polypeptide 11 |
chr7_-_141276729 | 8.55 |
ENSMUST00000167263.1
ENSMUST00000080654.5 |
Cdhr5
|
cadherin-related family member 5 |
chr2_+_102706356 | 8.47 |
ENSMUST00000123759.1
ENSMUST00000111212.1 ENSMUST00000005220.4 |
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr11_+_115462464 | 8.46 |
ENSMUST00000106532.3
ENSMUST00000092445.5 ENSMUST00000153466.1 |
Slc16a5
|
solute carrier family 16 (monocarboxylic acid transporters), member 5 |
chr11_-_5950018 | 8.28 |
ENSMUST00000102920.3
|
Gck
|
glucokinase |
chr7_-_99695809 | 8.11 |
ENSMUST00000107086.2
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr4_-_60222580 | 8.01 |
ENSMUST00000095058.4
ENSMUST00000163931.1 |
Mup8
|
major urinary protein 8 |
chr4_-_59960659 | 7.98 |
ENSMUST00000075973.2
|
Mup4
|
major urinary protein 4 |
chr7_-_105600103 | 7.92 |
ENSMUST00000033185.8
|
Hpx
|
hemopexin |
chr19_+_37697792 | 7.80 |
ENSMUST00000025946.5
|
Cyp26a1
|
cytochrome P450, family 26, subfamily a, polypeptide 1 |
chr11_-_115187321 | 7.61 |
ENSMUST00000103038.1
ENSMUST00000103039.1 ENSMUST00000103040.4 |
Nat9
|
N-acetyltransferase 9 (GCN5-related, putative) |
chr4_-_122961173 | 7.58 |
ENSMUST00000030408.5
ENSMUST00000127047.1 |
Mfsd2a
|
major facilitator superfamily domain containing 2A |
chr3_-_121815212 | 7.55 |
ENSMUST00000029770.5
|
Abcd3
|
ATP-binding cassette, sub-family D (ALD), member 3 |
chr19_+_39510844 | 7.47 |
ENSMUST00000025968.4
|
Cyp2c39
|
cytochrome P450, family 2, subfamily c, polypeptide 39 |
chr4_+_63344548 | 7.36 |
ENSMUST00000030044.2
|
Orm1
|
orosomucoid 1 |
chr11_+_72435511 | 7.32 |
ENSMUST00000076443.3
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr8_-_123236198 | 7.31 |
ENSMUST00000166768.1
ENSMUST00000098327.1 |
Spata2l
|
spermatogenesis associated 2-like |
chr19_+_12633507 | 7.30 |
ENSMUST00000119960.1
|
Glyat
|
glycine-N-acyltransferase |
chr8_+_105048592 | 7.26 |
ENSMUST00000093222.5
ENSMUST00000093223.3 |
Ces3a
|
carboxylesterase 3A |
chr7_-_97417730 | 7.23 |
ENSMUST00000043077.7
|
Thrsp
|
thyroid hormone responsive |
chr9_-_57683644 | 7.18 |
ENSMUST00000034860.3
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2 |
chr11_+_70054334 | 7.16 |
ENSMUST00000018699.6
ENSMUST00000108585.2 |
Asgr1
|
asialoglycoprotein receptor 1 |
chr3_-_113574242 | 7.16 |
ENSMUST00000142505.2
|
Amy1
|
amylase 1, salivary |
chr15_+_82452372 | 7.15 |
ENSMUST00000089129.5
|
Cyp2d9
|
cytochrome P450, family 2, subfamily d, polypeptide 9 |
chr1_+_166254095 | 7.05 |
ENSMUST00000111416.1
|
Ildr2
|
immunoglobulin-like domain containing receptor 2 |
chr10_+_127866457 | 7.00 |
ENSMUST00000092058.3
|
BC089597
|
cDNA sequence BC089597 |
chr11_+_72435565 | 6.98 |
ENSMUST00000100903.2
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr6_+_141629499 | 6.93 |
ENSMUST00000042812.6
|
Slco1b2
|
solute carrier organic anion transporter family, member 1b2 |
chr1_-_162984519 | 6.87 |
ENSMUST00000028010.7
|
Fmo3
|
flavin containing monooxygenase 3 |
chr11_+_72435534 | 6.85 |
ENSMUST00000108499.1
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr12_-_103457195 | 6.81 |
ENSMUST00000044687.6
|
Ifi27l2b
|
interferon, alpha-inducible protein 27 like 2B |
chr3_+_63295815 | 6.67 |
ENSMUST00000029400.1
|
Mme
|
membrane metallo endopeptidase |
chr1_-_162866502 | 6.65 |
ENSMUST00000046049.7
|
Fmo1
|
flavin containing monooxygenase 1 |
chr13_-_55426769 | 6.62 |
ENSMUST00000170921.1
|
F12
|
coagulation factor XII (Hageman factor) |
chr10_+_127759780 | 6.62 |
ENSMUST00000128247.1
|
RP23-386P10.11
|
Protein Rdh9 |
chr11_+_76679757 | 6.59 |
ENSMUST00000062024.2
|
Tusc5
|
tumor suppressor candidate 5 |
chr10_+_63024315 | 6.56 |
ENSMUST00000124784.1
|
Pbld2
|
phenazine biosynthesis-like protein domain containing 2 |
chr17_-_56117265 | 6.49 |
ENSMUST00000113072.2
|
Plin5
|
perilipin 5 |
chr13_-_55426783 | 6.48 |
ENSMUST00000021948.8
|
F12
|
coagulation factor XII (Hageman factor) |
chr9_+_46268601 | 6.48 |
ENSMUST00000121598.1
|
Apoa5
|
apolipoprotein A-V |
chrX_+_59999436 | 6.47 |
ENSMUST00000033477.4
|
F9
|
coagulation factor IX |
chr2_+_58755177 | 6.41 |
ENSMUST00000102755.3
|
Upp2
|
uridine phosphorylase 2 |
chr1_-_91413163 | 6.40 |
ENSMUST00000086851.1
|
Hes6
|
hairy and enhancer of split 6 |
chr10_-_127888688 | 6.32 |
ENSMUST00000047199.4
|
Rdh7
|
retinol dehydrogenase 7 |
chr1_-_162898665 | 6.30 |
ENSMUST00000111510.1
ENSMUST00000045902.6 |
Fmo2
|
flavin containing monooxygenase 2 |
chr15_-_82620907 | 6.28 |
ENSMUST00000109515.1
|
Cyp2d34
|
cytochrome P450, family 2, subfamily d, polypeptide 34 |
chr6_-_85933379 | 6.28 |
ENSMUST00000162660.1
|
Nat8b
|
N-acetyltransferase 8B |
chr4_-_108118504 | 6.24 |
ENSMUST00000149106.1
|
Scp2
|
sterol carrier protein 2, liver |
chr19_-_8218832 | 6.24 |
ENSMUST00000113298.2
|
Slc22a29
|
solute carrier family 22. member 29 |
chr10_-_127370535 | 6.21 |
ENSMUST00000026472.8
|
Inhbc
|
inhibin beta-C |
chr4_-_138326234 | 6.18 |
ENSMUST00000105817.3
ENSMUST00000030536.6 |
Pink1
|
PTEN induced putative kinase 1 |
chr3_-_113574758 | 6.16 |
ENSMUST00000106540.1
|
Amy1
|
amylase 1, salivary |
chr12_-_103773592 | 6.11 |
ENSMUST00000078869.5
|
Serpina1d
|
serine (or cysteine) peptidase inhibitor, clade A, member 1D |
chr19_+_3986564 | 6.09 |
ENSMUST00000054030.7
|
Acy3
|
aspartoacylase (aminoacylase) 3 |
chr2_-_25461094 | 6.03 |
ENSMUST00000114261.2
|
BC029214
|
cDNA sequence BC029214 |
chr19_+_12633303 | 6.03 |
ENSMUST00000044976.5
|
Glyat
|
glycine-N-acyltransferase |
chr10_+_128254131 | 5.97 |
ENSMUST00000060782.3
|
Apon
|
apolipoprotein N |
chr9_-_121916288 | 5.90 |
ENSMUST00000062474.4
|
Cyp8b1
|
cytochrome P450, family 8, subfamily b, polypeptide 1 |
chr4_+_115299046 | 5.86 |
ENSMUST00000084343.3
|
Cyp4a12a
|
cytochrome P450, family 4, subfamily a, polypeptide 12a |
chr2_-_25500613 | 5.83 |
ENSMUST00000040042.4
|
C8g
|
complement component 8, gamma polypeptide |
chr19_-_8131982 | 5.80 |
ENSMUST00000065651.4
|
Slc22a28
|
solute carrier family 22, member 28 |
chr1_-_121327734 | 5.69 |
ENSMUST00000160968.1
ENSMUST00000162582.1 |
Insig2
|
insulin induced gene 2 |
chr13_+_23870259 | 5.68 |
ENSMUST00000110413.1
|
Slc17a1
|
solute carrier family 17 (sodium phosphate), member 1 |
chr5_-_120503593 | 5.67 |
ENSMUST00000031597.6
|
Plbd2
|
phospholipase B domain containing 2 |
chr9_-_119157055 | 5.62 |
ENSMUST00000010795.4
|
Acaa1b
|
acetyl-Coenzyme A acyltransferase 1B |
chr4_-_114908892 | 5.62 |
ENSMUST00000068654.3
|
Foxd2
|
forkhead box D2 |
chr15_-_86033777 | 5.58 |
ENSMUST00000016172.7
|
Celsr1
|
cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo homolog, Drosophila) |
chrX_+_139800795 | 5.55 |
ENSMUST00000054889.3
|
Cldn2
|
claudin 2 |
chr7_+_26835305 | 5.53 |
ENSMUST00000005685.8
|
Cyp2a5
|
cytochrome P450, family 2, subfamily a, polypeptide 5 |
chr11_-_77519186 | 5.50 |
ENSMUST00000100807.2
|
Gm10392
|
predicted gene 10392 |
chr9_+_46240696 | 5.49 |
ENSMUST00000034585.6
|
Apoa4
|
apolipoprotein A-IV |
chr7_-_72306595 | 5.47 |
ENSMUST00000079323.5
|
Mctp2
|
multiple C2 domains, transmembrane 2 |
chr7_-_140154712 | 5.39 |
ENSMUST00000059241.7
|
Sprn
|
shadow of prion protein |
chr1_+_171214013 | 5.39 |
ENSMUST00000111328.1
|
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3 |
chr7_+_143473736 | 5.38 |
ENSMUST00000052348.5
|
Slc22a18
|
solute carrier family 22 (organic cation transporter), member 18 |
chr1_-_180195981 | 5.37 |
ENSMUST00000027766.6
ENSMUST00000161814.1 |
Adck3
|
aarF domain containing kinase 3 |
chr3_-_157925056 | 5.34 |
ENSMUST00000118539.1
|
Cth
|
cystathionase (cystathionine gamma-lyase) |
chr16_+_26581704 | 5.29 |
ENSMUST00000096129.2
ENSMUST00000166294.2 ENSMUST00000174202.1 ENSMUST00000023156.6 |
Il1rap
|
interleukin 1 receptor accessory protein |
chr8_-_25038875 | 5.22 |
ENSMUST00000084031.4
|
Htra4
|
HtrA serine peptidase 4 |
chr6_-_85832082 | 5.22 |
ENSMUST00000032073.6
|
Nat8
|
N-acetyltransferase 8 (GCN5-related, putative) |
chr16_-_97922582 | 5.20 |
ENSMUST00000170757.1
|
C2cd2
|
C2 calcium-dependent domain containing 2 |
chr7_+_51880312 | 5.19 |
ENSMUST00000145049.1
|
Gas2
|
growth arrest specific 2 |
chr8_-_93197799 | 5.15 |
ENSMUST00000034172.7
|
Ces1d
|
carboxylesterase 1D |
chr15_+_75449457 | 5.12 |
ENSMUST00000177479.1
|
Gm20654
|
predicted gene 20654 |
chr11_-_113708952 | 5.11 |
ENSMUST00000106617.1
|
Cpsf4l
|
cleavage and polyadenylation specific factor 4-like |
chr10_-_41587753 | 5.07 |
ENSMUST00000160751.1
|
Ccdc162
|
coiled-coil domain containing 162 |
chr2_+_32599698 | 5.02 |
ENSMUST00000131229.1
ENSMUST00000140983.1 ENSMUST00000095045.2 |
St6galnac6
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 |
chr17_+_32685655 | 5.00 |
ENSMUST00000008801.6
|
Cyp4f15
|
cytochrome P450, family 4, subfamily f, polypeptide 15 |
chr2_-_25501717 | 4.98 |
ENSMUST00000015227.3
|
C8g
|
complement component 8, gamma polypeptide |
chr18_-_32139570 | 4.98 |
ENSMUST00000171765.1
|
Proc
|
protein C |
chr17_+_27018005 | 4.98 |
ENSMUST00000122106.1
|
Ggnbp1
|
gametogenetin binding protein 1 |
chr1_-_136260873 | 4.95 |
ENSMUST00000086395.5
|
Gpr25
|
G protein-coupled receptor 25 |
chr9_-_103288224 | 4.94 |
ENSMUST00000123530.1
|
1300017J02Rik
|
RIKEN cDNA 1300017J02 gene |
chr7_-_12998140 | 4.92 |
ENSMUST00000032539.7
|
Slc27a5
|
solute carrier family 27 (fatty acid transporter), member 5 |
chr5_+_127632238 | 4.91 |
ENSMUST00000118139.1
|
Glt1d1
|
glycosyltransferase 1 domain containing 1 |
chr16_+_22920222 | 4.87 |
ENSMUST00000023587.4
ENSMUST00000116625.2 |
Fetub
|
fetuin beta |
chr9_-_103288290 | 4.86 |
ENSMUST00000035163.3
|
1300017J02Rik
|
RIKEN cDNA 1300017J02 gene |
chr17_-_31636631 | 4.84 |
ENSMUST00000135425.1
ENSMUST00000151718.1 ENSMUST00000155814.1 |
Cbs
|
cystathionine beta-synthase |
chr18_-_61911783 | 4.84 |
ENSMUST00000049378.8
ENSMUST00000166783.1 |
Ablim3
|
actin binding LIM protein family, member 3 |
chr10_+_63024512 | 4.83 |
ENSMUST00000020262.4
|
Pbld2
|
phenazine biosynthesis-like protein domain containing 2 |
chr6_+_124493101 | 4.82 |
ENSMUST00000049124.9
|
C1rl
|
complement component 1, r subcomponent-like |
chrX_-_100412587 | 4.78 |
ENSMUST00000033567.8
|
Awat2
|
acyl-CoA wax alcohol acyltransferase 2 |
chr17_+_47436731 | 4.77 |
ENSMUST00000150819.2
|
AI661453
|
expressed sequence AI661453 |
chr7_-_12998172 | 4.77 |
ENSMUST00000120903.1
|
Slc27a5
|
solute carrier family 27 (fatty acid transporter), member 5 |
chr1_+_171213969 | 4.76 |
ENSMUST00000005820.4
ENSMUST00000075469.5 ENSMUST00000155126.1 |
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3 |
chr15_-_82394022 | 4.73 |
ENSMUST00000170255.1
|
Cyp2d11
|
cytochrome P450, family 2, subfamily d, polypeptide 11 |
chr7_-_126676357 | 4.71 |
ENSMUST00000106371.1
ENSMUST00000106372.3 ENSMUST00000155419.1 |
Sult1a1
|
sulfotransferase family 1A, phenol-preferring, member 1 |
chr8_+_45658666 | 4.70 |
ENSMUST00000134675.1
ENSMUST00000139869.1 ENSMUST00000126067.1 |
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr2_+_58754910 | 4.69 |
ENSMUST00000059102.6
|
Upp2
|
uridine phosphorylase 2 |
chr7_+_119617804 | 4.68 |
ENSMUST00000135683.1
|
Acsm1
|
acyl-CoA synthetase medium-chain family member 1 |
chr14_-_57104693 | 4.64 |
ENSMUST00000055698.7
|
Gjb2
|
gap junction protein, beta 2 |
chr10_+_18845071 | 4.60 |
ENSMUST00000019998.7
|
Perp
|
PERP, TP53 apoptosis effector |
chr17_+_35470083 | 4.59 |
ENSMUST00000174525.1
ENSMUST00000068291.6 |
H2-Q10
|
histocompatibility 2, Q region locus 10 |
chr18_-_38211957 | 4.58 |
ENSMUST00000159405.1
ENSMUST00000160721.1 |
Pcdh1
|
protocadherin 1 |
chr7_-_84151868 | 4.56 |
ENSMUST00000117085.1
|
Abhd17c
|
abhydrolase domain containing 17C |
chr13_-_19307551 | 4.54 |
ENSMUST00000103561.1
|
Tcrg-C2
|
T-cell receptor gamma, constant 2 |
chr4_+_141368116 | 4.52 |
ENSMUST00000006380.4
|
Fam131c
|
family with sequence similarity 131, member C |
chr9_-_86695897 | 4.51 |
ENSMUST00000034989.8
|
Me1
|
malic enzyme 1, NADP(+)-dependent, cytosolic |
chr5_-_45450121 | 4.50 |
ENSMUST00000127562.1
|
Qdpr
|
quinoid dihydropteridine reductase |
chr2_+_25395866 | 4.48 |
ENSMUST00000028328.2
|
Entpd2
|
ectonucleoside triphosphate diphosphohydrolase 2 |
chr7_-_30973399 | 4.46 |
ENSMUST00000098553.4
ENSMUST00000147431.1 |
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr13_-_93637961 | 4.45 |
ENSMUST00000099309.4
|
Bhmt
|
betaine-homocysteine methyltransferase |
chr17_-_56117577 | 4.44 |
ENSMUST00000019808.5
|
Plin5
|
perilipin 5 |
chr6_-_129237948 | 4.39 |
ENSMUST00000181238.1
ENSMUST00000180379.1 |
2310001H17Rik
|
RIKEN cDNA 2310001H17 gene |
chr7_-_97579382 | 4.39 |
ENSMUST00000151840.1
ENSMUST00000135998.1 ENSMUST00000144858.1 ENSMUST00000146605.1 ENSMUST00000072725.5 ENSMUST00000138060.1 ENSMUST00000154853.1 ENSMUST00000136757.1 ENSMUST00000124552.1 |
Aamdc
|
adipogenesis associated Mth938 domain containing |
chr7_-_126676428 | 4.37 |
ENSMUST00000106373.1
|
Sult1a1
|
sulfotransferase family 1A, phenol-preferring, member 1 |
chr5_-_77115145 | 4.34 |
ENSMUST00000081964.5
|
Hopx
|
HOP homeobox |
chr19_-_40187277 | 4.34 |
ENSMUST00000051846.6
|
Cyp2c70
|
cytochrome P450, family 2, subfamily c, polypeptide 70 |
chr2_+_27079371 | 4.30 |
ENSMUST00000091233.6
|
Adamtsl2
|
ADAMTS-like 2 |
chr7_-_132576372 | 4.27 |
ENSMUST00000084500.6
|
Oat
|
ornithine aminotransferase |
chr6_-_85915653 | 4.27 |
ENSMUST00000161198.2
|
Cml1
|
camello-like 1 |
chr2_-_25470031 | 4.25 |
ENSMUST00000114251.1
|
Ptgds
|
prostaglandin D2 synthase (brain) |
chr17_-_34862473 | 4.23 |
ENSMUST00000025229.4
ENSMUST00000176203.2 ENSMUST00000128767.1 |
Cfb
|
complement factor B |
chr17_-_34862122 | 4.23 |
ENSMUST00000154526.1
|
Cfb
|
complement factor B |
chr3_+_40846970 | 4.21 |
ENSMUST00000108078.2
|
3110057O12Rik
|
RIKEN cDNA 3110057O12 gene |
chr7_+_65862029 | 4.19 |
ENSMUST00000055576.5
ENSMUST00000098391.4 |
Pcsk6
|
proprotein convertase subtilisin/kexin type 6 |
chr7_-_30973367 | 4.17 |
ENSMUST00000108116.3
|
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr10_-_75781411 | 4.16 |
ENSMUST00000001715.3
|
Gstt3
|
glutathione S-transferase, theta 3 |
chr11_+_83709015 | 4.15 |
ENSMUST00000001009.7
|
Wfdc18
|
WAP four-disulfide core domain 18 |
chr8_-_120634379 | 4.15 |
ENSMUST00000123927.1
|
1190005I06Rik
|
RIKEN cDNA 1190005I06 gene |
chr9_-_22002599 | 4.13 |
ENSMUST00000115336.2
ENSMUST00000044926.5 |
Ccdc151
|
coiled-coil domain containing 151 |
chr16_+_37580137 | 4.09 |
ENSMUST00000160847.1
|
Hgd
|
homogentisate 1, 2-dioxygenase |
chr13_+_23870284 | 4.08 |
ENSMUST00000006785.7
|
Slc17a1
|
solute carrier family 17 (sodium phosphate), member 1 |
chr12_-_103863551 | 4.08 |
ENSMUST00000085056.6
ENSMUST00000072876.5 ENSMUST00000124717.1 |
Serpina1a
|
serine (or cysteine) peptidase inhibitor, clade A, member 1A |
chr17_+_32685610 | 4.04 |
ENSMUST00000168171.1
|
Cyp4f15
|
cytochrome P450, family 4, subfamily f, polypeptide 15 |
chr11_+_48837465 | 4.04 |
ENSMUST00000046903.5
|
Trim7
|
tripartite motif-containing 7 |
chr5_-_53213447 | 4.01 |
ENSMUST00000031090.6
|
Sel1l3
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
chr18_+_51117754 | 4.00 |
ENSMUST00000116639.2
|
Prr16
|
proline rich 16 |
chr11_+_73199445 | 4.00 |
ENSMUST00000006105.6
|
Shpk
|
sedoheptulokinase |
chr3_+_60031754 | 3.99 |
ENSMUST00000029325.3
|
Aadac
|
arylacetamide deacetylase (esterase) |
chr4_-_89294608 | 3.99 |
ENSMUST00000107131.1
|
Cdkn2a
|
cyclin-dependent kinase inhibitor 2A |
chr1_+_191906743 | 3.97 |
ENSMUST00000044954.6
|
Slc30a1
|
solute carrier family 30 (zinc transporter), member 1 |
chr13_-_41847626 | 3.97 |
ENSMUST00000121404.1
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr8_-_3467617 | 3.96 |
ENSMUST00000111081.3
ENSMUST00000118194.1 ENSMUST00000004686.6 |
Pex11g
|
peroxisomal biogenesis factor 11 gamma |
chr7_-_140102326 | 3.95 |
ENSMUST00000128527.1
|
Fuom
|
fucose mutarotase |
chr11_+_114851814 | 3.95 |
ENSMUST00000053361.5
ENSMUST00000021071.7 ENSMUST00000136785.1 |
Gprc5c
|
G protein-coupled receptor, family C, group 5, member C |
chr17_+_56162477 | 3.92 |
ENSMUST00000077788.6
|
Tnfaip8l1
|
tumor necrosis factor, alpha-induced protein 8-like 1 |
chr14_+_51091077 | 3.91 |
ENSMUST00000022428.5
ENSMUST00000171688.1 |
Rnase4
Ang
|
ribonuclease, RNase A family 4 angiogenin, ribonuclease, RNase A family, 5 |
chr1_+_88055377 | 3.91 |
ENSMUST00000138182.1
ENSMUST00000113142.3 |
Ugt1a10
|
UDP glycosyltransferase 1 family, polypeptide A10 |
chr8_-_3717547 | 3.90 |
ENSMUST00000058040.6
|
Gm9814
|
predicted gene 9814 |
chr6_-_85915604 | 3.90 |
ENSMUST00000174369.1
|
Cml1
|
camello-like 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.9 | 31.7 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
7.9 | 31.6 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
5.6 | 16.9 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
4.4 | 13.1 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
4.2 | 21.0 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
4.1 | 12.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
3.9 | 11.6 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
3.7 | 11.2 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) |
3.4 | 10.2 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
3.1 | 9.4 | GO:0006533 | aspartate catabolic process(GO:0006533) |
2.9 | 8.8 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
2.9 | 95.9 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
2.8 | 8.3 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
2.8 | 2.8 | GO:0009441 | glycolate metabolic process(GO:0009441) |
2.7 | 10.9 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
2.6 | 10.3 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
2.5 | 10.1 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
2.5 | 7.5 | GO:0018900 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
2.4 | 9.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
2.4 | 7.2 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
2.4 | 61.8 | GO:0035634 | response to stilbenoid(GO:0035634) |
2.3 | 13.9 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
2.3 | 9.2 | GO:0032382 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
2.2 | 6.6 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
2.1 | 6.4 | GO:0051977 | lysophospholipid transport(GO:0051977) |
2.1 | 8.3 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
2.1 | 10.3 | GO:0015886 | heme transport(GO:0015886) |
2.1 | 12.3 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.9 | 1.9 | GO:0009804 | coumarin metabolic process(GO:0009804) |
1.9 | 9.5 | GO:1904970 | brush border assembly(GO:1904970) |
1.9 | 3.8 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
1.8 | 5.5 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
1.7 | 5.2 | GO:1901377 | mycotoxin metabolic process(GO:0043385) mycotoxin catabolic process(GO:0043387) aflatoxin metabolic process(GO:0046222) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound metabolic process(GO:1901376) organic heteropentacyclic compound catabolic process(GO:1901377) |
1.7 | 5.2 | GO:0042853 | glycine biosynthetic process, by transamination of glyoxylate(GO:0019265) L-alanine catabolic process(GO:0042853) |
1.7 | 8.5 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
1.7 | 26.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.6 | 4.8 | GO:0009407 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
1.6 | 1.6 | GO:0006551 | leucine metabolic process(GO:0006551) |
1.6 | 4.8 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
1.6 | 26.9 | GO:0052695 | cellular glucuronidation(GO:0052695) |
1.5 | 4.6 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
1.5 | 6.2 | GO:1903384 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
1.5 | 15.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
1.5 | 7.5 | GO:0032902 | nerve growth factor production(GO:0032902) |
1.5 | 20.6 | GO:0015747 | urate transport(GO:0015747) |
1.5 | 4.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
1.5 | 2.9 | GO:1902022 | L-lysine transport(GO:1902022) |
1.4 | 4.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.4 | 51.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
1.3 | 4.0 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
1.3 | 15.6 | GO:0032782 | bile acid secretion(GO:0032782) |
1.3 | 3.8 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
1.3 | 6.3 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) |
1.2 | 3.7 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.2 | 7.4 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
1.2 | 3.7 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
1.2 | 12.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
1.2 | 8.5 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.2 | 9.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.2 | 10.6 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
1.2 | 4.6 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
1.2 | 1.2 | GO:0060846 | arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
1.2 | 9.2 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
1.1 | 1.1 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
1.1 | 2.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
1.1 | 5.7 | GO:0008295 | spermidine biosynthetic process(GO:0008295) putrescine biosynthetic process(GO:0009446) |
1.1 | 5.6 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
1.1 | 4.4 | GO:0002434 | immune complex clearance(GO:0002434) |
1.1 | 3.3 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
1.1 | 6.5 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
1.1 | 13.0 | GO:0046415 | urate metabolic process(GO:0046415) |
1.1 | 1.1 | GO:1902730 | positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.1 | 3.2 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
1.1 | 8.5 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
1.1 | 6.3 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
1.1 | 3.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.0 | 5.0 | GO:0006548 | histidine catabolic process(GO:0006548) |
1.0 | 4.0 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
1.0 | 9.8 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
1.0 | 1.9 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
1.0 | 15.2 | GO:0017144 | drug metabolic process(GO:0017144) |
0.9 | 8.4 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.9 | 4.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.9 | 1.9 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
0.9 | 5.6 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.9 | 2.8 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.9 | 3.7 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.9 | 2.7 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.9 | 3.6 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.9 | 2.7 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.9 | 3.6 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.9 | 4.5 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.9 | 5.3 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.9 | 6.2 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.9 | 14.9 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.9 | 6.1 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.9 | 1.7 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.9 | 2.6 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.9 | 3.4 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.8 | 4.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.8 | 0.8 | GO:2000451 | positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) |
0.8 | 2.4 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
0.8 | 4.9 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.8 | 4.8 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.8 | 3.2 | GO:2000256 | positive regulation of male germ cell proliferation(GO:2000256) |
0.8 | 4.8 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.8 | 3.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.8 | 3.9 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.8 | 3.1 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.8 | 3.8 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
0.8 | 3.8 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.8 | 5.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.8 | 3.0 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
0.8 | 3.8 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.8 | 12.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.7 | 9.0 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.7 | 3.6 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.7 | 5.7 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.7 | 4.3 | GO:0034214 | protein hexamerization(GO:0034214) |
0.7 | 3.4 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.7 | 4.1 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.7 | 2.0 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.7 | 2.7 | GO:0030070 | insulin processing(GO:0030070) |
0.7 | 2.0 | GO:0051030 | RNA import into nucleus(GO:0006404) snRNA transport(GO:0051030) |
0.7 | 7.3 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.7 | 4.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.7 | 1.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.6 | 1.9 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
0.6 | 2.6 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.6 | 5.7 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.6 | 6.3 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.6 | 3.8 | GO:0033762 | response to glucagon(GO:0033762) |
0.6 | 1.9 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
0.6 | 3.7 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.6 | 2.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.6 | 1.2 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.6 | 1.2 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
0.6 | 2.4 | GO:0090126 | protein complex assembly involved in synapse maturation(GO:0090126) |
0.6 | 1.8 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.6 | 1.8 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.6 | 1.2 | GO:0015817 | histidine transport(GO:0015817) |
0.6 | 3.6 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.6 | 2.9 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.6 | 7.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.6 | 1.7 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
0.6 | 1.7 | GO:0045074 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.6 | 3.9 | GO:0070189 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
0.6 | 5.5 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.5 | 2.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.5 | 1.6 | GO:0060490 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.5 | 4.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.5 | 4.3 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.5 | 6.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.5 | 6.4 | GO:0099638 | endosome to plasma membrane protein transport(GO:0099638) |
0.5 | 1.6 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.5 | 1.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.5 | 1.6 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.5 | 2.1 | GO:0072061 | inner medullary collecting duct development(GO:0072061) negative regulation of nodal signaling pathway(GO:1900108) |
0.5 | 2.1 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.5 | 2.1 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.5 | 3.6 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.5 | 1.5 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.5 | 5.6 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.5 | 2.5 | GO:0001997 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.5 | 1.5 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.5 | 4.5 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
0.5 | 0.5 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.5 | 2.4 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.5 | 2.4 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.5 | 2.4 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.5 | 1.9 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.5 | 1.9 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.5 | 1.4 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.5 | 4.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.5 | 4.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.5 | 1.8 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.5 | 1.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.5 | 2.3 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.4 | 3.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.4 | 2.7 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.4 | 1.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.4 | 1.8 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.4 | 3.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.4 | 1.3 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.4 | 1.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.4 | 1.3 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.4 | 1.3 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.4 | 0.9 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.4 | 5.5 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.4 | 2.9 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.4 | 1.2 | GO:0007172 | signal complex assembly(GO:0007172) regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.4 | 2.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.4 | 3.3 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.4 | 0.8 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.4 | 5.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.4 | 1.2 | GO:0009155 | purine deoxyribonucleotide catabolic process(GO:0009155) purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.4 | 2.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.4 | 1.2 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
0.4 | 2.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.4 | 4.0 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.4 | 1.2 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.4 | 0.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.4 | 1.2 | GO:0043519 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.4 | 1.2 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.4 | 0.8 | GO:0035787 | cell migration involved in kidney development(GO:0035787) |
0.4 | 2.3 | GO:0001757 | somite specification(GO:0001757) |
0.4 | 1.1 | GO:1905204 | septum secundum development(GO:0003285) cardiac muscle tissue regeneration(GO:0061026) negative regulation of connective tissue replacement(GO:1905204) |
0.4 | 1.9 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.4 | 1.1 | GO:1903294 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
0.4 | 1.5 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.4 | 1.9 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.4 | 2.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.4 | 1.5 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.4 | 5.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.4 | 4.0 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.4 | 1.5 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.4 | 0.7 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
0.4 | 2.9 | GO:0015671 | oxygen transport(GO:0015671) |
0.4 | 1.4 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.4 | 6.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.4 | 2.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 2.1 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.3 | 3.1 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
0.3 | 0.7 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.3 | 1.3 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.3 | 1.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.3 | 1.0 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.3 | 2.3 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.3 | 2.7 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.3 | 13.6 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.3 | 3.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.3 | 2.6 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.3 | 2.6 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.3 | 13.8 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 2.6 | GO:0019695 | choline metabolic process(GO:0019695) |
0.3 | 1.0 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.3 | 2.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.3 | 1.0 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.3 | 1.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 1.0 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.3 | 4.4 | GO:0002934 | desmosome organization(GO:0002934) |
0.3 | 15.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.3 | 2.5 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.3 | 0.6 | GO:0046618 | drug export(GO:0046618) |
0.3 | 2.5 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.3 | 1.6 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.3 | 0.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.3 | 0.9 | GO:0072014 | proximal tubule development(GO:0072014) |
0.3 | 0.6 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.3 | 2.4 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.3 | 1.8 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.3 | 0.9 | GO:0060594 | mammary gland specification(GO:0060594) |
0.3 | 0.9 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.3 | 2.7 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.3 | 1.2 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.3 | 2.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.3 | 1.8 | GO:0009249 | protein lipoylation(GO:0009249) |
0.3 | 6.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.3 | 2.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.3 | 4.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.3 | 3.1 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.3 | 6.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.3 | 0.9 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 1.1 | GO:1903028 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.3 | 0.8 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.3 | 2.3 | GO:0006901 | vesicle coating(GO:0006901) |
0.3 | 0.8 | GO:1904954 | Spemann organizer formation(GO:0060061) canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
0.3 | 0.8 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.3 | 3.3 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 1.1 | GO:0015744 | succinate transport(GO:0015744) |
0.3 | 1.9 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.3 | 3.0 | GO:0097264 | self proteolysis(GO:0097264) |
0.3 | 1.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.3 | 1.6 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.3 | 1.6 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.3 | 10.4 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 0.8 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
0.3 | 2.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.3 | 1.6 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.3 | 0.8 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
0.3 | 0.5 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
0.3 | 0.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.3 | 4.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 3.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.3 | 5.9 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 0.5 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.3 | 0.5 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.3 | 0.8 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.3 | 5.5 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 3.7 | GO:0098792 | xenophagy(GO:0098792) |
0.2 | 0.7 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.2 | 1.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.2 | 0.7 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.2 | 0.5 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.2 | 1.0 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.7 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.7 | GO:0002879 | acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.2 | 0.7 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.2 | 5.7 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.2 | 1.4 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.2 | 1.4 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.2 | 0.7 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.2 | 0.7 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
0.2 | 0.7 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 1.6 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.2 | 1.1 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.2 | 2.9 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.2 | 0.7 | GO:0099542 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.2 | 1.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 4.2 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 3.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 2.4 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 1.3 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.2 | 3.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.6 | GO:0021634 | optic nerve formation(GO:0021634) optic chiasma development(GO:0061360) regulation of optic nerve formation(GO:2000595) positive regulation of optic nerve formation(GO:2000597) |
0.2 | 0.9 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.2 | 1.1 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.2 | 0.6 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.2 | 13.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 1.3 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.2 | 0.6 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.2 | 1.6 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.2 | 1.2 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 1.0 | GO:0045925 | sperm ejaculation(GO:0042713) positive regulation of female receptivity(GO:0045925) |
0.2 | 2.7 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.2 | 0.6 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.2 | 1.8 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 0.4 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.2 | 0.8 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.2 | 0.8 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.2 | 2.8 | GO:0051608 | histamine transport(GO:0051608) |
0.2 | 2.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 1.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 2.0 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 1.0 | GO:0000237 | leptotene(GO:0000237) |
0.2 | 0.8 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 0.6 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.2 | 3.7 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 5.5 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.2 | 0.6 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.2 | 4.7 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 1.4 | GO:0015862 | uridine transport(GO:0015862) |
0.2 | 1.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.2 | 1.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.2 | 2.5 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.2 | 3.1 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.2 | 1.7 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 1.1 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.2 | 3.0 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.2 | 1.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.6 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 1.9 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 0.7 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.6 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 1.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 2.6 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.2 | 1.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 1.2 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.2 | 0.7 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.2 | 0.7 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.2 | 0.5 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.2 | 2.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 1.4 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.2 | 0.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 1.0 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.2 | 10.0 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 4.8 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.2 | 0.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 2.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 2.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.2 | 1.5 | GO:0009301 | snRNA transcription(GO:0009301) |
0.2 | 5.8 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.2 | 1.5 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.2 | 0.5 | GO:0015881 | creatine transport(GO:0015881) |
0.2 | 1.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 0.8 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 1.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 2.1 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.2 | 1.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.8 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.2 | 1.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 0.3 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 1.1 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 10.0 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.2 | 0.5 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.2 | 2.1 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 1.3 | GO:0015669 | gas transport(GO:0015669) |
0.2 | 0.5 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 1.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 0.8 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.2 | 0.8 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.2 | 1.1 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.2 | 0.5 | GO:0000239 | pachytene(GO:0000239) |
0.2 | 1.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.4 | GO:0010513 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) regulation of phosphatidylinositol biosynthetic process(GO:0010511) positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.1 | 1.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.3 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.1 | 0.3 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.1 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.1 | 2.5 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.4 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.1 | 6.8 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 1.3 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.1 | 0.9 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.9 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
0.1 | 0.4 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 1.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 1.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.7 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.4 | GO:0090649 | cellular response to manganese ion(GO:0071287) response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.1 | 2.6 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.4 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.1 | 5.0 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.1 | 1.2 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.5 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 1.9 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.5 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 1.4 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.1 | 0.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 1.9 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.5 | GO:0072321 | protein import into mitochondrial inner membrane(GO:0045039) chaperone-mediated protein transport(GO:0072321) |
0.1 | 4.3 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.5 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.1 | 0.8 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 1.9 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 1.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) regulation of establishment of protein localization to plasma membrane(GO:0090003) |
0.1 | 0.8 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.8 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.5 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.9 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 6.5 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.1 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.1 | 1.9 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.1 | 3.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 1.0 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.8 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 1.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.9 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.5 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.4 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.1 | 0.6 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.1 | 1.4 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 1.5 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 2.7 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 1.9 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 1.6 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.6 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 0.3 | GO:0052042 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
0.1 | 1.0 | GO:0072017 | distal tubule development(GO:0072017) |
0.1 | 1.7 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.1 | 0.1 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.1 | 1.4 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 1.2 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.5 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.7 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.1 | 0.3 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.2 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.9 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.7 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.1 | 2.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 2.9 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 1.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 2.0 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.9 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.6 | GO:1901911 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.1 | 0.4 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 2.6 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.7 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.9 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 0.7 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 6.2 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.1 | 0.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 1.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 3.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.3 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.3 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
0.1 | 1.7 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 0.4 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.4 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.6 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.4 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.1 | 0.4 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 1.3 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.7 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.4 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.1 | 4.3 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.4 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.1 | 2.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.5 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.2 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.5 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 4.2 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.1 | 0.5 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.1 | 3.2 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.2 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of isotype switching to IgE isotypes(GO:0048295) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.1 | 1.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 2.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.7 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.4 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
0.1 | 2.9 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 1.4 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.4 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.1 | 0.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 1.0 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.6 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.1 | 0.4 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 1.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 5.5 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.3 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.1 | 0.5 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.1 | 0.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.3 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.7 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 0.4 | GO:0007210 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) serotonin receptor signaling pathway(GO:0007210) |
0.1 | 1.1 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.1 | 1.2 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.1 | 2.1 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.7 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.5 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.4 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 1.0 | GO:0033753 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.1 | 0.3 | GO:0089700 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) protein kinase D signaling(GO:0089700) |
0.1 | 0.3 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.1 | 0.6 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 2.0 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.1 | 0.8 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 1.3 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.2 | GO:0048338 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
0.1 | 0.3 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 1.7 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.7 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 1.5 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.1 | 2.1 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 1.2 | GO:0060479 | lung cell differentiation(GO:0060479) |
0.1 | 0.1 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 1.6 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 1.5 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.9 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 1.0 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.1 | 0.4 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 0.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.8 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 0.2 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 0.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 1.4 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 0.1 | GO:0070649 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
0.1 | 0.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.5 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.1 | 0.3 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 1.3 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.1 | 0.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.4 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.7 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.1 | 0.2 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.0 | GO:0030576 | Cajal body organization(GO:0030576) |
0.0 | 0.6 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.1 | GO:0016598 | protein arginylation(GO:0016598) |
0.0 | 0.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.0 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.2 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.0 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 5.7 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.0 | 0.3 | GO:0060430 | lung saccule development(GO:0060430) |
0.0 | 0.9 | GO:0034340 | response to type I interferon(GO:0034340) |
0.0 | 0.9 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 1.6 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.0 | 0.1 | GO:0061386 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.0 | 0.5 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.0 | 0.6 | GO:0006573 | valine metabolic process(GO:0006573) |
0.0 | 0.6 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.6 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.0 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 | 0.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.7 | GO:0007041 | lysosomal transport(GO:0007041) |
0.0 | 0.3 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.2 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.0 | 0.4 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.5 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.3 | GO:0030035 | microspike assembly(GO:0030035) |
0.0 | 0.5 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.0 | 0.4 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.0 | 0.2 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.0 | 0.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.0 | 0.3 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.5 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.4 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.1 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.0 | 0.2 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 3.6 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.7 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.3 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 1.2 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 | 0.4 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.2 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.0 | 0.4 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.1 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.0 | 0.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
0.0 | 0.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.8 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.9 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.5 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.0 | 0.9 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 1.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 2.8 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.2 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.0 | 0.3 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.1 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.6 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.2 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.6 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.1 | GO:0030578 | PML body organization(GO:0030578) |
0.0 | 0.5 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.0 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.0 | 0.2 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.0 | 0.3 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.3 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.1 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 1.9 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.3 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.1 | GO:0097421 | liver regeneration(GO:0097421) |
0.0 | 0.2 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) |
0.0 | 0.4 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.0 | 0.4 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.0 | 1.0 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.2 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 0.8 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.0 | 0.7 | GO:1902652 | cholesterol metabolic process(GO:0008203) secondary alcohol metabolic process(GO:1902652) |
0.0 | 0.1 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 30.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
2.4 | 26.0 | GO:0042627 | chylomicron(GO:0042627) |
1.9 | 21.2 | GO:0005579 | membrane attack complex(GO:0005579) |
1.8 | 8.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.7 | 5.2 | GO:0005713 | recombination nodule(GO:0005713) |
1.7 | 13.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.5 | 4.4 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
1.4 | 22.8 | GO:0045180 | basal cortex(GO:0045180) |
1.4 | 11.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.2 | 33.5 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
1.1 | 10.9 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
1.0 | 5.8 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.0 | 20.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.9 | 3.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.9 | 10.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.8 | 8.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.8 | 10.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.8 | 11.5 | GO:0097449 | astrocyte projection(GO:0097449) |
0.6 | 1.9 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.6 | 1.8 | GO:0044754 | autolysosome(GO:0044754) |
0.6 | 48.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.6 | 4.0 | GO:0001652 | granular component(GO:0001652) |
0.6 | 1.1 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.6 | 1.7 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.6 | 1.7 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.5 | 0.5 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.5 | 1.6 | GO:0044299 | C-fiber(GO:0044299) |
0.5 | 1.6 | GO:0098855 | HCN channel complex(GO:0098855) |
0.5 | 2.6 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.5 | 2.6 | GO:1990037 | Lewy body core(GO:1990037) |
0.5 | 2.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 4.2 | GO:0043219 | lateral loop(GO:0043219) |
0.5 | 2.3 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.4 | 3.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.4 | 3.3 | GO:0042825 | TAP complex(GO:0042825) |
0.4 | 2.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.4 | 9.0 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.4 | 6.1 | GO:0043203 | axon hillock(GO:0043203) |
0.4 | 1.6 | GO:0035339 | SPOTS complex(GO:0035339) |
0.4 | 2.8 | GO:0070695 | FHF complex(GO:0070695) |
0.4 | 4.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 20.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.4 | 74.3 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.4 | 2.3 | GO:0097441 | basilar dendrite(GO:0097441) |
0.3 | 7.9 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 2.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.3 | 3.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.3 | 2.3 | GO:1990357 | terminal web(GO:1990357) |
0.3 | 3.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.3 | 10.7 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.3 | 1.6 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 0.9 | GO:0016507 | mitochondrial fatty acid beta-oxidation multienzyme complex(GO:0016507) fatty acid beta-oxidation multienzyme complex(GO:0036125) |
0.3 | 3.0 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.3 | 2.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.3 | 0.3 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.3 | 1.2 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.3 | 1.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 5.7 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 1.9 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.3 | 1.1 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 9.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 2.9 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 0.8 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.3 | 0.8 | GO:0097413 | Lewy body(GO:0097413) |
0.3 | 2.1 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 3.2 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.2 | 0.5 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 1.9 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 2.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 0.9 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 2.1 | GO:0061617 | MICOS complex(GO:0061617) |
0.2 | 4.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 1.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 2.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.2 | 3.4 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 2.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 0.8 | GO:0036019 | endolysosome(GO:0036019) |
0.2 | 1.0 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 5.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 0.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 9.3 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 0.6 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.2 | 0.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 1.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 1.3 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.2 | 0.6 | GO:0032280 | symmetric synapse(GO:0032280) |
0.2 | 15.4 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 3.0 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 1.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 3.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 4.0 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.2 | 0.9 | GO:0005914 | spot adherens junction(GO:0005914) |
0.2 | 68.7 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 1.1 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.2 | 16.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.2 | 0.7 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
0.2 | 0.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 2.2 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 1.8 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 7.1 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 0.5 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.2 | 1.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 250.5 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.2 | 2.9 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 0.8 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 0.5 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) cytoplasmic side of late endosome membrane(GO:0098560) cytoplasmic side of lysosomal membrane(GO:0098574) |
0.1 | 2.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 24.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 1.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.5 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.7 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 1.3 | GO:0000801 | central element(GO:0000801) |
0.1 | 3.0 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.4 | GO:0035841 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
0.1 | 2.6 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.8 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 2.2 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.7 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) cation-transporting ATPase complex(GO:0090533) |
0.1 | 2.1 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.4 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 2.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.5 | GO:0097361 | CIA complex(GO:0097361) |
0.1 | 1.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.5 | GO:0097433 | dense body(GO:0097433) |
0.1 | 1.8 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 0.8 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 2.4 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 1.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 2.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 2.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.6 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.6 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 4.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 1.5 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.1 | 0.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 1.9 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.7 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 1.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.4 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 1.0 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 1.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 1.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.4 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.4 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.3 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.7 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.5 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.2 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.1 | 8.6 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 58.1 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 2.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 5.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.0 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 1.0 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.8 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.3 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.2 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.9 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) CNTFR-CLCF1 complex(GO:0097059) |
0.0 | 0.8 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 1.1 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.8 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.9 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.5 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 2.0 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.3 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.6 | GO:0044298 | cell body membrane(GO:0044298) |
0.0 | 0.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.7 | 52.3 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
8.4 | 33.5 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
8.0 | 23.9 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
6.3 | 18.8 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
5.1 | 20.4 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
3.7 | 11.0 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
3.4 | 10.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
3.3 | 13.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
3.1 | 9.3 | GO:0005118 | sevenless binding(GO:0005118) |
2.9 | 14.6 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
2.8 | 13.9 | GO:0004925 | prolactin receptor activity(GO:0004925) |
2.6 | 10.3 | GO:0015232 | heme transporter activity(GO:0015232) |
2.6 | 12.9 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
2.5 | 7.5 | GO:0047651 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
2.4 | 9.4 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
2.3 | 9.2 | GO:1904121 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
2.2 | 11.1 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
2.2 | 45.8 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
2.2 | 6.5 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
2.1 | 32.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
2.1 | 21.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
2.1 | 46.7 | GO:0070330 | aromatase activity(GO:0070330) |
2.0 | 12.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.9 | 13.3 | GO:0004556 | alpha-amylase activity(GO:0004556) |
1.8 | 5.5 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
1.8 | 7.3 | GO:0042806 | fucose binding(GO:0042806) |
1.8 | 5.3 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
1.7 | 5.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.6 | 4.8 | GO:0098809 | nitrite reductase activity(GO:0098809) |
1.6 | 4.8 | GO:0030614 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
1.6 | 4.8 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
1.6 | 57.1 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
1.6 | 17.2 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
1.6 | 23.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.5 | 7.7 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.5 | 4.5 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
1.4 | 2.9 | GO:0004096 | catalase activity(GO:0004096) |
1.4 | 8.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
1.4 | 5.6 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
1.3 | 13.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.3 | 10.4 | GO:0035473 | lipase binding(GO:0035473) |
1.3 | 6.3 | GO:0008142 | oxysterol binding(GO:0008142) |
1.3 | 5.0 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
1.2 | 3.7 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
1.2 | 4.8 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.2 | 3.6 | GO:0008431 | vitamin E binding(GO:0008431) |
1.1 | 26.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
1.1 | 3.3 | GO:0004998 | transferrin receptor activity(GO:0004998) |
1.1 | 3.3 | GO:0031403 | lithium ion binding(GO:0031403) |
1.1 | 9.8 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.1 | 27.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
1.1 | 4.3 | GO:0050436 | microfibril binding(GO:0050436) |
1.1 | 7.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.0 | 5.1 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
1.0 | 4.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.0 | 24.2 | GO:0071949 | FAD binding(GO:0071949) |
1.0 | 4.0 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
1.0 | 5.0 | GO:0070012 | oligopeptidase activity(GO:0070012) |
1.0 | 3.0 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
1.0 | 5.9 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.0 | 2.9 | GO:0016855 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
1.0 | 8.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.9 | 0.9 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.9 | 2.8 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.9 | 6.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.9 | 3.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.9 | 3.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.9 | 10.8 | GO:0019841 | retinol binding(GO:0019841) |
0.9 | 9.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.9 | 5.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.9 | 1.8 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.9 | 2.6 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.9 | 2.6 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.9 | 5.2 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.9 | 2.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.8 | 3.3 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.8 | 2.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.8 | 10.6 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.8 | 4.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.8 | 4.5 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.8 | 2.3 | GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
0.8 | 3.8 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.7 | 8.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.7 | 4.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.7 | 27.9 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.7 | 6.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.7 | 2.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.7 | 2.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.7 | 9.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.7 | 7.0 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.7 | 4.7 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.7 | 2.6 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.6 | 1.9 | GO:0004063 | aryldialkylphosphatase activity(GO:0004063) |
0.6 | 1.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.6 | 7.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.6 | 3.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.6 | 1.8 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.6 | 10.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.6 | 2.3 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
0.6 | 2.9 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.6 | 1.7 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
0.6 | 6.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.6 | 2.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.6 | 15.0 | GO:0005550 | pheromone binding(GO:0005550) |
0.6 | 1.7 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
0.6 | 1.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.6 | 6.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.6 | 5.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.5 | 5.5 | GO:0008494 | translation activator activity(GO:0008494) |
0.5 | 3.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.5 | 7.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.5 | 2.7 | GO:0034584 | piRNA binding(GO:0034584) |
0.5 | 2.1 | GO:0055105 | ubiquitin-protein transferase inhibitor activity(GO:0055105) |
0.5 | 2.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.5 | 3.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.5 | 2.6 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.5 | 4.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.5 | 2.0 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.5 | 0.5 | GO:0005119 | smoothened binding(GO:0005119) |
0.5 | 4.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.5 | 21.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.5 | 1.5 | GO:0047874 | dolichyldiphosphatase activity(GO:0047874) |
0.5 | 1.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.5 | 2.9 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.5 | 1.4 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.5 | 3.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.5 | 2.4 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.5 | 2.4 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) tapasin binding(GO:0046980) |
0.5 | 1.4 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.5 | 1.9 | GO:0019970 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.5 | 5.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.5 | 9.7 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.5 | 1.8 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.5 | 2.3 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.4 | 6.7 | GO:0015250 | water channel activity(GO:0015250) |
0.4 | 1.3 | GO:0070905 | serine binding(GO:0070905) |
0.4 | 1.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.4 | 1.7 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.4 | 1.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.4 | 1.7 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.4 | 2.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.4 | 6.8 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.4 | 2.5 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.4 | 4.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.4 | 2.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.4 | 4.5 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.4 | 2.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.4 | 0.8 | GO:0035877 | death effector domain binding(GO:0035877) |
0.4 | 5.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.4 | 1.2 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.4 | 1.6 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.4 | 15.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.4 | 5.0 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.4 | 12.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.4 | 1.1 | GO:0071820 | N-box binding(GO:0071820) |
0.4 | 2.7 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.4 | 5.7 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.4 | 1.5 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.4 | 5.6 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.4 | 1.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.4 | 1.5 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.4 | 2.9 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.4 | 1.1 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
0.3 | 1.7 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.3 | 2.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.3 | 1.4 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.3 | 1.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 1.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 4.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.3 | 2.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 1.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 12.9 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.3 | 3.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 1.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 1.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.3 | 1.3 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
0.3 | 8.4 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.3 | 1.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 1.6 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 3.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 6.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.3 | 1.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.3 | 2.8 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.3 | 1.2 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.3 | 2.9 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.3 | 2.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 4.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.3 | 4.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 2.0 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.3 | 7.7 | GO:0005506 | iron ion binding(GO:0005506) |
0.3 | 5.7 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.3 | 1.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 2.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 3.3 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.3 | 6.1 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 1.9 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.3 | 1.1 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.3 | 1.6 | GO:0004103 | choline kinase activity(GO:0004103) |
0.3 | 1.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 1.9 | GO:0038132 | neuregulin binding(GO:0038132) |
0.3 | 2.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.3 | 1.1 | GO:0055100 | adiponectin binding(GO:0055100) adipokinetic hormone receptor activity(GO:0097003) |
0.3 | 1.6 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.3 | 2.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 2.6 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.3 | 1.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 6.6 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.3 | 34.2 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.3 | 3.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 1.5 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 1.5 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.2 | 1.0 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.2 | 1.0 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 0.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 2.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.2 | 0.9 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 0.7 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.2 | 0.7 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.2 | 2.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.2 | 2.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 2.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 3.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 1.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 1.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.2 | 1.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 0.6 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.2 | 1.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 27.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 1.6 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 1.8 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 4.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 3.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 3.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 1.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 2.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 1.3 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.2 | 3.6 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.2 | 2.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.2 | 1.9 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 0.6 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.2 | 0.6 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.2 | 3.8 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.2 | 6.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 0.7 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 0.4 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 1.2 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 1.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.5 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.2 | 2.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 0.7 | GO:0001639 | PLC activating G-protein coupled glutamate receptor activity(GO:0001639) G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) |
0.2 | 0.5 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.2 | 0.5 | GO:0051747 | cytosine C-5 DNA demethylase activity(GO:0051747) |
0.2 | 2.4 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.2 | 4.2 | GO:0050661 | NADP binding(GO:0050661) |
0.2 | 0.6 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.2 | 1.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 2.8 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.2 | 1.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 2.3 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 2.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 0.8 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 3.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.7 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 2.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 2.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 2.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 10.2 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 1.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.9 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.7 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) adenyl deoxyribonucleotide binding(GO:0032558) |
0.1 | 10.0 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.1 | 1.8 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.9 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 3.0 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 2.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 1.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 2.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.8 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.1 | 0.2 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.1 | 0.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 2.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 2.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 3.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 1.3 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.6 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 2.2 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.3 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
0.1 | 1.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 1.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 2.0 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 2.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 4.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.4 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.1 | 0.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 2.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 1.3 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.7 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 5.0 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.4 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 3.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 1.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 1.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 1.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 7.4 | GO:0008238 | exopeptidase activity(GO:0008238) |
0.1 | 0.3 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.1 | 1.8 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 3.0 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 3.3 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 1.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.6 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 1.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.9 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 1.0 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.1 | 0.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 2.5 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 2.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.3 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 0.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 1.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 2.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.5 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 1.6 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 1.2 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 5.7 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.9 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 2.9 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 2.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 3.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.3 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 0.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.7 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.9 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 5.7 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 4.0 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 0.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.4 | GO:1990430 | G-protein coupled GABA receptor activity(GO:0004965) extracellular matrix protein binding(GO:1990430) |
0.1 | 0.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.9 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 2.0 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.2 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.1 | 1.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 2.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.7 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.7 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.0 | 2.4 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 3.6 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 1.5 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 0.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 1.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.4 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.3 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.0 | 1.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 1.1 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 1.2 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 1.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 1.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.9 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 2.5 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.0 | 0.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.1 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.0 | 0.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 2.1 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 1.2 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.2 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.0 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.3 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.0 | 0.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 1.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 9.2 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 4.6 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.3 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 1.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 2.1 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 1.9 | GO:0016853 | isomerase activity(GO:0016853) |
0.0 | 0.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.2 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.1 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.0 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 0.3 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.5 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.0 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.0 | 2.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.1 | GO:0043121 | neurotrophin binding(GO:0043121) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 4.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 12.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.4 | 3.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.3 | 19.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.3 | 8.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 8.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 1.8 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 12.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 3.8 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 2.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 2.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 4.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 12.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 3.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 5.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 11.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 1.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 4.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 32.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 6.3 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 7.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 2.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 2.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 4.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 10.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 5.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 5.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 2.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 3.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 1.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 1.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 2.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 1.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 1.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 9.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
2.4 | 7.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
2.1 | 30.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
2.1 | 22.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
2.1 | 26.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
2.0 | 28.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.6 | 41.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.3 | 1.3 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
1.3 | 11.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
1.2 | 37.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
1.1 | 6.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
1.1 | 10.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.9 | 35.9 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.9 | 11.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.9 | 14.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.9 | 11.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.7 | 6.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.7 | 19.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.6 | 23.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.6 | 11.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.6 | 12.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.6 | 10.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.6 | 4.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.5 | 2.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.5 | 3.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.5 | 7.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.5 | 5.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.4 | 7.0 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.4 | 11.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.4 | 9.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.4 | 6.8 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.4 | 1.6 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.4 | 5.0 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.4 | 5.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.4 | 2.9 | REACTOME OPSINS | Genes involved in Opsins |
0.4 | 4.3 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.4 | 8.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 4.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.3 | 5.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.3 | 10.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.3 | 19.7 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.3 | 49.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.3 | 5.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.3 | 3.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 3.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 23.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 1.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 4.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 11.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 17.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.2 | 4.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 2.4 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.2 | 3.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 2.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.2 | 2.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 5.2 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.2 | 7.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 2.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 3.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 2.4 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.2 | 2.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 2.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 1.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 0.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 1.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 9.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.8 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 2.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 2.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 6.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 6.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 3.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 3.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 2.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 5.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 7.5 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 3.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.4 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 3.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 1.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 1.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 1.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 6.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.9 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 2.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 1.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.2 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 1.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 1.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 1.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 7.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 2.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 1.8 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 1.1 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |